RJA
DPLO

Raymond James & Associates’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Raymond James & Associates’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-29,159
Closed -$169K – 3803
2019
Q1 		$169K Buy
+29,159
New +$301K ﹤0.01% 3294
2018
Q3 		– Sell
-9,553
Closed -$244K – 3770
2018
Q2 		$244K Buy
+9,553
New +$223K ﹤0.01% 3142
2018
Q1 		– Sell
-11,861
Closed -$238K – 3637
2017
Q4 		$238K Sell
11,861
-25,163
-68% -$495K ﹤0.01% 2961
2017
Q3 		$767K Buy
37,024
+1,800
+5% +$30.4K ﹤0.01% 2250
2017
Q2 		$521K Sell
35,224
-2,171
-6% -$36.2K ﹤0.01% 2390
2017
Q1 		$596K Buy
37,395
+1,935
+5% +$27.9K ﹤0.01% 2278
2016
Q4 		$447K Buy
35,460
+5,435
+18% +$101K ﹤0.01% 2402
2016
Q3 		$841K Sell
30,025
-1,327
-4% -$44.5K ﹤0.01% 1983
2016
Q2 		$1.1M Sell
31,352
-4,720
-13% -$148K ﹤0.01% 1688
2016
Q1 		$988K Buy
36,072
+9,833
+37% +$290K ﹤0.01% 1669
2015
Q4 		$898K Sell
26,239
-51
-0.2% -$1.59K ﹤0.01% 1693
2015
Q3 		$755K Buy
26,290
+9,790
+59% +$419K ﹤0.01% 1743
2015
Q2 		$738K Buy
+16,500
New +$621K ﹤0.01% 1874

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SI
Stephens Inc Little Rock, Arkansas $7.99B AUM 21.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Raymond James & Associates's DPLO Position: Q2 2019 in Review

Raymond James & Associates sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q2 2019, closing a stake of 29,159 shares — an estimated $169K sold.

Raymond James & Associates first reported a position in DPLO in Q2 2015 and held it in 13 quarters. The position peaked at $1.1M in Q2 2016. 131 funds tracked by Wall St. Rank hold DPLO as of Q2 2019.

  • Raymond James & Associates reported no remaining DIPLOMAT PHARMACY, INC. position as of Q2 2019 after selling out during the quarter.
  • Raymond James & Associates sold 29,159 DIPLOMAT PHARMACY, INC. shares in Q2 2019, an estimated $169K.
  • Raymond James & Associates first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2015 and held it in 13 quarters.
  • Raymond James & Associates's DIPLOMAT PHARMACY, INC. position peaked at $1.1M in Q2 2016.
  • 131 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q2 2019.

Based on Raymond James & Associates's 13F filing for Q2 2019, filed 6 Aug 2019.